BTG4P1

Across TCGA pan-cancer cohorts, BTG4P1 RNA is linked to patient survival in 5 of 34 cancer types, making it the most broadly survival-associated BTG4P1 data layer.

The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where higher BTG4P1 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated BTG4P1 expression acts as an unfavorable survival marker.

UCEC, STAD, and SKCM are the cancer types where BTG4P1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UCEC	OS	Tertile	II,III,IV	0.198	0.768	.002	108	view →
STAD	OS	Tertile	All	0.328	0.587	.019	45	view →
SKCM	DFS	Tertile	All	0.073	0.762	<.001	45	view →
LGG	DFS	Tertile	All	0.185	0.826	<.001	18	view →
SARC	DFS	Tertile	All	0.095	0.632	.002	18	view →

Pink = unfavorable, green = favorable. Showing the 5 strongest of 5 lineages.

BTG4P1–UCEC (OS)

Open the UCEC breakdown →